Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women

NCT03464266 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03464266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03464266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Concurrent Initiation of DMPA Contraception and Tenofovir PrEP on Bone Loss in Young Women
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Completed
Start date
May 15, 2018
Completion date
December 21, 2023
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone demineralization, bone microarchitecture, hypoestrogenism, subclinical kidney injury